Folic acid handling by the human gut: implications for food fortification and supplementation

被引:88
作者
Patanwala, Imran [1 ]
King, Maria J. [2 ]
Barrett, David A. [3 ]
Rose, John [4 ]
Jackson, Ralph [4 ]
Hudson, Mark [1 ]
Philo, Mark [2 ]
Dainty, Jack R. [2 ]
Wright, Anthony J. A. [2 ]
Finglas, Paul M. [2 ]
Jones, David E. [1 ]
机构
[1] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Inst Food Res, Norwich NR4 7UA, Norfolk, England
[3] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2RD, England
[4] Freeman Rd Hosp, Dept Radiol, Newcastle Upon Tyne, Tyne & Wear, England
基金
英国生物技术与生命科学研究理事会;
关键词
DIHYDROFOLATE-REDUCTASE; INTESTINAL-ABSORPTION; PTEROYLGLUTAMIC ACID; FOLATE; CANCER; HOMOCYSTEINE; METHYLATION; TRANSPORT; RISK; 5-METHYLTETRAHYDROFOLATE;
D O I
10.3945/ajcn.113.080507
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Current thinking, which is based mainly on rodent studies, is that physiologic doses of folic acid (pterylmonoglutamic acid), such as dietary vitamin folates, are biotransformed in the intestinal mucosa and transferred to the portal vein as the natural circulating plasma folate, 5-methyltetrahydrofolic acid (5-MTHF) before entering the liver and the wider systemic blood supply. Objective: We tested the assumption that, in humans, folic acid is biotransformed (reduced and methylated) to 5-MTHF in the intestinal mucosa. Design: We conducted a crossover study in which we sampled portal and peripheral veins for labeled folate concentrations after oral ingestion with physiologic doses of stable-isotope labeled folic acid or the reduced folate 5-formyltetrahydrofolic acid (5Formy1THF) in 6 subjects with a transjugular intrahepatic porto systemic shunt (TIPSS) in situ. The TIPSS allowed blood samples to be taken from the portal vein. Results: Fifteen minutes after a dose of folic acid, 80 12% of labeled folate in the hepatic portal vein was unmodified folic acid. In contrast, after a dose of labeled 5-Formy1THF, only 4 18% of labeled folate in the portal vein was unmodified 5-Formy1THF, and the rest had been converted to 5-MTHF after 15 min (postdose). Conclusions: The human gut appears to have a very efficient capacity to convert reduced dietary folates to 5-MTHF but limited ability to reduce folic acid. Therefore, large amounts of unmodified folic acid in the portal vein are probably attributable to an extremely limited mucosal cell dihydrofolate reductase (DHFR) capacity that is necessary to produce tetrahydrofolic acid before sequential methylation to 5-MTHF. This process would suggest that humans are reliant on the liver for folic acid reduction even though it has a low and highly variable DIAFR activity. Therefore, chronic liver exposure to folic acid in humans may induce saturation, which would possibly explain reports of systemic circulation of unmetabolized folic acid.
引用
收藏
页码:593 / 599
页数:7
相关论文
共 33 条
  • [1] Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged ≥60 y in the United States
    Bailey, Regan L.
    Mills, James L.
    Yetley, Elizabeth A.
    Gahche, Jaime J.
    Pfeiffer, Christine M.
    Dwyer, Johanna T.
    Dodd, Kevin W.
    Sempos, Christopher T.
    Betz, Joseph M.
    Picciano, Mary Frances
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 92 (02) : 383 - 389
  • [2] The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake
    Bailey, Steven W.
    Ayling, June E.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (36) : 15424 - 15429
  • [3] Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5
  • [4] Quantifying the Dose-Response Relationship Between Circulating Folate Concentrations and Colorectal Cancer in Cohort Studies: A Meta-Analysis Based on a Flexible Meta-Regression Model
    Chuang, Shu-Chun
    Rota, Matteo
    Gunter, Marc J.
    Zeleniuch-Jacquotte, Anne
    Eussen, Simone J. P. M.
    Vollset, Stein Emil
    Ueland, Per Magne
    Norat, Teresa
    Ziegler, Regina G.
    Vineis, Paolo
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (07) : 1028 - 1037
  • [5] PREVENTION OF THE 1ST OCCURRENCE OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATION
    CZEIZEL, AE
    DUDAS, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (26) : 1832 - 1835
  • [6] Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis
    Duthie, Susan J.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 (01) : 101 - 109
  • [7] Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical Trial
    Figueiredo, Jane C.
    Grau, Maria V.
    Haile, Robert W.
    Sandler, Robert S.
    Summers, Robert W.
    Bresalier, Robert S.
    Burke, Carol A.
    McKeown-Eyssen, Gail E.
    Baron, John A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (06): : 432 - 435
  • [8] Colon cancer in Chile before and after the start of the flour fortification program with folic acid
    Hirsch, Sandra
    Sanchez, Hugo
    Albala, Cecilia
    Pia de la Maza, Maria
    Barrera, Gladys
    Leiva, Laura
    Bunout, Daniel
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (04) : 346 - 349
  • [9] LACK OF DIHYDROFOLATE-REDUCTASE IN HUMAN-TUMOR AND LEUKEMIA-CELLS INVIVO
    KAMEN, BA
    NYLEN, PA
    WHITEHEAD, VM
    ABELSON, HT
    DOLNICK, BJ
    PETERSON, DW
    [J]. CANCER DRUG DELIVERY, 1985, 2 (02): : 133 - 138
  • [10] Estimation of the 5-Methyltetrahydrofolate Apparent Volume of Distribution in Humans
    King, Maria J.
    Brima, Eid I.
    Dainty, Jack R.
    Barrett, David A.
    Wright, Anthony J.
    Willis, Gavin
    Finglas, Paul M.
    [J]. JOURNAL OF NUTRITION, 2012, 142 (02) : 389 - 395